Submissions from 2023
A Randomized Study of Low-Intensity Focused Ultrasound for Blood-Brain Barrier Disruption for Brain Metastasis from Non-Small Cell Lung Cancer (LIMITLESS), Manmeet Ahluwalia, Michael McDermott, Ahmad Ozair, and Atulya Khosla
Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis, Manmeet Ahluwalia and Minesh Mehta
Enhancing lung cancer screening through ‘Saved by the Scan’: Lessons from a multipronged public service advertising program., Shreyas Bellur, Ahmad Ozair, Atulya Khosla, Juan Batlle, Mark Dylewski, and Manmeet Ahluwalia
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha
Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer, Alonso La Rosa de los Rios, Kathryn Mittauer, Michael Chuong, Matthew Hall, Tugce Kutuk, Nema Bassiri-Gharb, James McCulloch, Diane Alvarez, Raul Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases, Ahmad Ozair, Atulya Khosla, Shreya Saxena, and Manmeet Ahluwalia
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline, Hina Saeed
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study, Shreya Saxena, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, and Manmeet Ahluwalia
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study, Shreya Saxena, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, and Manmeet Ahluwalia
Submissions from 2022
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis, Federico Albrecht, Rupesh Kotecha, and Zhenwei Zhang
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer, Jessika Contreras
Keynote B36: Open-label study of first-line tumor treating fields (150kHz) plus pembrolizumab for non-small cell lung cancer, Rupesh Kotecha
Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha and Federico Albrecht
Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers, Tugce Kutuk
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors, Tugce Kutuk, Rupesh Kotecha, Manmeet Ahluwalia, and Minesh Mehta
Role of Radiotherapy in Brain Metastases from Lung Cancer, Minesh Mehta
Pralsetinib (Gavreto): Treatment of metastatic non-small-cell lung cancer in patients positive for RET fusions, Shanada Monestime
Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer, Shanada Monestime
Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy, Suresh Rana
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer, Miguel Villalona Calero
Submissions from 2021
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting, Juan Batlle
Bone Metastases in Lung Cancer, Ana Cecilia Belzarena Genovese
Case report of visual biofeedback-driven, magnetic resonance-guided single-fraction SABR in breath hold for early stage non-small-cell lung cancer, Michael Chuong, Rupesh Kotecha, Minesh Mehta, Sonia Adamson, Tino Romaguera, Matthew Hall, Diane Alvarez, Alonso Gutierrez, Vivek Mishra, Fernando De Zarraga, and Kathryn Mittauer
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia
Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Minesh Mehta, Michael McDermott, manmeet Ahluwalia, and Rupesh Kotecha
Systemic Therapy and Radiation Therapy in Lung Cancer, Raees Tonse, Martin Tom, and Rupesh Kotecha
Submissions from 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero
Submissions from 2019
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero
Submissions from 2018
A five-step strategy for building an LDCT lung cancer screening program, Juan Batlle, Muhammad Latif, and Ricardo Cury
Robotic resection of Stage III lung cancer: an international retrospective study, Mark Dylewski
The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study, Mark Dylewski
Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta
Adaptive planning and toxicities of uniform scanning proton therapy for lung cancer patients, Suresh Rana
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero
Submissions from 2017
Robotic assisted lobectomy for locally advanced lung cancer, Mark Dylewski
Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta
Submissions from 2013
Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Brain Metastases from Non-Small Cell Lung Cancer: An International Multicenter Study of 395 Patients, Ahmad Ozair, Atulya Khosla, and Manmeet Ahluwalia
Submissions from 2012
Learning Curve and Oncological Radicality of Robotic-assisted Lobectomy for Lung Cancer, Mark Dylewski
Submissions from 2007
Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife, William Brown, Alan Lewin, and Andre Abitbol